Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for ZIM Laboratories Limited as of 30 June 2025 is 3,690.65 MM.
- The operating income for ZIM Laboratories Limited as of 30 June 2025 is 208.74 MM.
- The net income for ZIM Laboratories Limited as of 30 June 2025 is 93.92 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 3,690.65 | 208.74 | 93.92 |
2025-03-31 | 3,791.33 | 245.73 | 121.65 |
2024-12-31 | 3,882.53 | 263.31 | 153.66 |
2024-09-30 | 3,882.16 | 272.46 | 161.50 |
2024-06-30 | 3,818.99 | 279.56 | 179.18 |
2024-03-31 | 3,675.17 | 256.66 | 172.46 |
2023-12-31 | 3,550.54 | 249.02 | 163.97 |
2023-09-30 | 3,597.32 | 264.99 | 182.13 |
2023-06-30 | 3,733.07 | 291.50 | 195.13 |
2023-03-31 | 3,986.09 | 352.59 | 244.34 |
2022-12-31 | 3,982.63 | 346.58 | 242.28 |
2022-09-30 | 3,840.09 | 323.12 | 217.00 |
2022-06-30 | 3,619.99 | 302.47 | 195.09 |
2022-03-31 | 3,335.09 | 250.31 | 145.50 |
2021-12-31 | 3,022.92 | 192.25 | 90.70 |
2021-09-30 | 2,904.82 | 160.10 | 62.89 |
2021-06-30 | 3,009.60 | 188.75 | 42.25 |
2021-03-31 | 3,073.45 | 240.55 | 73.17 |
2020-12-31 | 3,026.98 | 242.51 | 80.65 |
2020-09-30 | 3,011.37 | 248.79 | 82.94 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 3.15 | 3.15 |
2024-09-30 | 3.30 | 3.30 |
2024-06-30 | 3.59 | 3.59 |
2024-03-31 | 3.54 | 3.54 |
2023-12-31 | 3.36 | 3.36 |
2023-09-30 | 3.74 | 3.73 |
2023-06-30 | 4.07 | 4.07 |
2023-03-31 | 5.01 | 5.01 |
2022-12-31 | 4.98 | 4.98 |
2022-09-30 | 4.45 | 4.46 |
2022-06-30 | 3.97 | 3.97 |
2022-03-31 | 2.99 | 2.99 |
2021-12-31 | 1.86 | 1.86 |
2021-09-30 | 1.29 | 1.29 |
2021-06-30 | 0.87 | 0.87 |
2021-03-31 | 1.50 | 1.50 |
2020-12-31 | 1.65 | 1.65 |
2020-09-30 | 1.71 | 1.71 |
2020-06-30 | 1.35 | 1.35 |
2020-03-31 | 0.68 | 0.68 |
Cash Flow: Operations, Investing, Financing
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | 411.55 | -399.27 | -91.05 |
2024-12-31 | |||
2024-09-30 | 299.18 | -646.72 | 247.24 |
2024-06-30 | |||
2024-03-31 | 162.78 | -730.13 | 595.34 |
2023-12-31 | |||
2023-09-30 | 524.29 | -560.35 | 106.77 |
2023-06-30 | |||
2023-03-31 | 381.68 | -362.04 | 5.46 |
2022-12-31 | |||
2022-09-30 | 549.94 | -212.52 | -300.37 |
2022-06-30 | |||
2022-03-31 | 492.06 | -145.71 | -329.70 |
2021-12-31 | |||
2021-09-30 | 155.97 | -113.07 | -53.33 |
2021-06-30 | |||
2021-03-31 | 318.51 | -58.81 | -259.74 |
2020-12-31 | |||
2020-09-30 | 354.88 | -88.69 | -246.08 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for ZIM Laboratories Limited as of 30 June 2025 is 44.19.
- The p/book for ZIM Laboratories Limited as of 30 June 2025 is 2.13.
- The p/tbv for ZIM Laboratories Limited as of 30 June 2025 is 2.44.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 44.19 | 2.13 | 2.44 |
2025-03-31 | 25.76 | 1.63 | 1.85 |
2024-12-31 | 33.10 | 2.20 | 2.49 |
2024-09-30 | 30.27 | 2.27 | 2.51 |
2024-06-30 | 29.67 | 2.14 | 2.37 |
2024-03-31 | 29.52 | 2.14 | 2.31 |
2023-12-31 | 27.83 | 2.24 | 2.42 |
2023-09-30 | 24.11 | 2.35 | 2.53 |
2023-06-30 | 25.84 | 2.52 | 2.71 |
2023-03-31 | 20.77 | 2.53 | 2.73 |
2022-12-31 | 23.28 | 2.70 | 2.90 |
2022-09-30 | 23.28 | 2.70 | 2.90 |
2022-06-30 | 25.84 | 2.87 | 3.05 |
2022-03-31 | 34.75 | 2.88 | 3.06 |
2021-12-31 | 55.50 | 3.07 | 3.28 |
2021-09-30 | 80.69 | 3.09 | 3.31 |
2021-06-30 | 115.91 | 3.05 | 3.29 |
2021-03-31 | 69.13 | 3.15 | 3.40 |
2020-12-31 | 62.73 | 3.20 | 3.47 |
2020-09-30 | 61.47 | 3.23 | 3.50 |
2020-06-30 | 77.94 | 3.29 | 3.60 |
2020-03-31 | 153.91 | 3.30 | 3.61 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for ZIM Laboratories Limited as of 30 June 2025 is 0.03.
- The ebit (3y)/ev for ZIM Laboratories Limited as of 30 June 2025 is 0.03.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 0.03 | 0.03 |
2025-03-31 | 0.04 | 0.05 |
2024-12-31 | 0.04 | 0.04 |
2024-09-30 | 0.04 | 0.04 |
2024-06-30 | 0.04 | 0.04 |
2024-03-31 | 0.04 | 0.05 |
2023-12-31 | 0.05 | 0.04 |
2023-09-30 | 0.05 | 0.04 |
2023-06-30 | 0.05 | 0.04 |
2023-03-31 | 0.06 | 0.04 |
2022-12-31 | 0.06 | 0.03 |
2022-09-30 | 0.06 | 0.03 |
2022-06-30 | 0.05 | 0.02 |
2022-03-31 | 0.04 | 0.02 |
2021-12-31 | 0.02 | 0.01 |
2021-09-30 | 0.01 | 0.01 |
2021-06-30 | 0.01 | 0.02 |
2021-03-31 | 0.02 | 0.02 |
2020-12-31 | 0.02 | 0.02 |
2020-09-30 | 0.02 | 0.03 |
2020-06-30 | 0.01 | 0.03 |
2020-03-31 | 0.00 | 0.03 |
Management Effectiveness
- The roa for ZIM Laboratories Limited as of 30 June 2025 is 0.03.
- The roe for ZIM Laboratories Limited as of 30 June 2025 is 0.04.
- The roic for ZIM Laboratories Limited as of 30 June 2025 is 0.03.
- The croic for ZIM Laboratories Limited as of 30 June 2025 is -0.02.
- The ocroic for ZIM Laboratories Limited as of 30 June 2025 is 0.10.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.03 | 0.04 | 0.03 | -0.02 | 0.10 |
2025-03-31 | 0.04 | 0.07 | 0.04 | -0.03 | 0.09 |
2024-12-31 | 0.04 | 0.07 | 0.05 | -0.03 | 0.09 |
2024-09-30 | 0.05 | 0.07 | 0.04 | 0.01 | 0.04 |
2024-06-30 | 0.05 | 0.09 | 0.04 | 0.01 | 0.04 |
2024-03-31 | 0.05 | 0.09 | 0.06 | 0.03 | 0.18 |
2023-12-31 | 0.05 | 0.10 | 0.06 | 0.03 | 0.18 |
2023-09-30 | 0.06 | 0.11 | 0.07 | 0.01 | 0.13 |
2023-06-30 | 0.06 | 0.11 | 0.07 | 0.01 | 0.13 |
2023-03-31 | 0.07 | 0.14 | 0.09 | 0.01 | 0.13 |
2022-12-31 | 0.07 | 0.13 | 0.09 | 0.02 | 0.22 |
2022-09-30 | 0.07 | 0.13 | 0.08 | 0.02 | 0.20 |
2022-06-30 | 0.06 | 0.12 | 0.08 | 0.01 | 0.20 |
2022-03-31 | 0.04 | 0.09 | 0.06 | 0.01 | 0.20 |
2021-12-31 | 0.03 | 0.06 | 0.04 | -0.00 | 0.06 |
2021-09-30 | 0.02 | 0.04 | 0.02 | -0.00 | 0.05 |
2021-06-30 | 0.01 | 0.03 | 0.02 | -0.00 | 0.13 |
2021-03-31 | 0.02 | 0.05 | 0.03 | -0.00 | 0.13 |
2020-12-31 | 0.02 | 0.05 | 0.04 | 0.01 | 0.16 |
2020-09-30 | 0.02 | 0.06 | 0.03 | 0.01 | 0.15 |
2020-06-30 | 0.02 | 0.04 | 0.03 | 0.00 | 0.09 |
2020-03-31 | 0.01 | 0.02 | 0.01 | 0.00 | 0.09 |
Gross Margins
- The gross margin for ZIM Laboratories Limited as of 30 June 2025 is 0.56.
- The net margin for ZIM Laboratories Limited as of 30 June 2025 is 0.03.
- The operating margin for ZIM Laboratories Limited as of 30 June 2025 is 0.06.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.56 | 0.03 | 0.06 |
2025-03-31 | 0.52 | 0.04 | 0.07 |
2024-12-31 | 0.51 | 0.04 | 0.07 |
2024-09-30 | 0.51 | 0.05 | 0.07 |
2024-06-30 | 0.53 | 0.05 | 0.07 |
2024-03-31 | 0.51 | 0.05 | 0.07 |
2023-12-31 | 0.50 | 0.05 | 0.07 |
2023-09-30 | 0.48 | 0.05 | 0.08 |
2023-06-30 | 0.48 | 0.05 | 0.08 |
2023-03-31 | 0.50 | 0.06 | 0.09 |
2022-12-31 | 0.49 | 0.06 | 0.08 |
2022-09-30 | 0.49 | 0.06 | 0.08 |
2022-06-30 | 0.50 | 0.05 | 0.08 |
2022-03-31 | 0.52 | 0.04 | 0.07 |
2021-12-31 | 0.50 | 0.03 | 0.06 |
2021-09-30 | 0.50 | 0.02 | 0.06 |
2021-06-30 | 0.47 | 0.01 | 0.06 |
2021-03-31 | 0.47 | 0.02 | 0.08 |
2020-12-31 | 0.47 | 0.03 | 0.08 |
2020-09-30 | 0.46 | 0.03 | 0.08 |
2020-06-30 | 0.48 | 0.02 | 0.06 |
2020-03-31 | 0.48 | 0.01 | 0.03 |
Identifiers and Descriptors
Central Index Key (CIK) |